.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Theraplant is stocked at 68 licensed dispensaries across Connecticut, with the deepest coverage in New Haven, Newington, Bridgeport, Danbury, and Hamden. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Theraplant’s mix concentrated in Vapor Pens at 32.54% share and Pre-Roll at 32.30%, with Flower close behind at 29.50%, while Capsules, Tincture & Sublingual, and Topical together accounted for 5.66%. Year over year, Pre-Roll expanded 76.49% and Flower rose 66.29%, contrasting with a 47.94% decline in Vapor Pens and a 49.34% drop in Capsules; month over month, Vapor Pens inched up 1.57% and Pre-Roll was flat at 0.03% as Flower slipped 2.18%. Against a brand-level price decline of 25.70% year over year and overall sales down 8.08% year over year, the category tilt toward Pre-Roll and Flower signals a volume-led mix that offsets Vapor Pen contraction, implying a deliberate pivot to higher-throughput segments while preserving presence in Vapor Pens, where the brand holds rank 3 in Connecticut.
The shift — expanding Pre-Roll by 76.49% and Flower by 66.29% while Vapor Pens fell 47.94% and Capsules fell 49.34% — implies Theraplant is trading margin for share and basket frequency, consistent with an average price that is 25.70% lower year over year. With Vapor Pens still at 32.54% share and up 1.57% month over month, and Pre-Roll steady at 0.03% month over month, the brand appears to be stabilizing its inhalable base while compressing lower-velocity formats like Tincture & Sublingual by 24.19% month over month; the net effect positions Theraplant to compete on accessible price points and scale in inhalables, while treating Capsules’ 9.41% month-over-month uptick as a tactical, not strategic, contributor.
Competitive Landscape
Theraplant is ranked #3 in CT Vapor Pens in July 2026, down 2 positions year over year from #1, while maintaining #3 since April 2026; in contrast, Select moved up to #1 from #4 with 105.2% YoY sales growth, and Lighthouse Cannabis Company advanced to #2 from #3 with 46.0% YoY growth. Theraplant’s peak at #1 in December 2025 and subsequent slide to #3, paired with Amigos (CT) jumping to #4 from #18 with a 38,321.8% YoY surge, indicates a reshuffling where competitor acceleration outpaces Theraplant’s recent stability, implying the brand must convert consistency at #3 into regained momentum to reverse its rank decline.
Notable Products
Pinyatti Pre-Roll (1g) set the tone in July 2026 with a -19.2% month-over-month decline and a slide to rank 3, indicating demand rotation away from legacy singles while two infused 2g Fat Boy Pre-Rolls sat higher on revenue despite ranks at 4 and 9. Pink Certz Pre-Roll (1g) rose 39.3% MoM at rank 8 while Gastro Fuel Pre-Roll (1g) held rank 1 with no reported MoM rate, and seven of the top ten were Pre-Roll SKUs, concentrating share in one format and implying portfolio reliance on combustion over Flower and Vapor Pens ($100,521 for Sunny Sundaze Pure Co2 Mini Tank Disposable (0.5g) at rank 6). The pattern implies Theraplant is leaning into infused and value-forward Pre-Rolls to drive unit turns, with Flower and Vapor positioned as secondary traffic drivers rather than rank leaders.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
